Cardiac disease that needs the implantation of cardiac devices.
Conditions
Interventions
Intervention 1: Intervention Group 1: The drugs included Morphine sulfate 0.05 mg per kilogram of body weight, administered slowly via injection. If the patient was over 70 years old or had COPD, the
if the patient is over 70 years old or has COPD, the received dose is halved. Additionally, Andanestron 4 mg—equivalent to one ampoule in 100 cc of normal saline—and Apotel 1 g—equivalent to one ampou
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Cardiac patients older than 18 years old that need to implantation of cardiac devices
Exclusion criteria
Exclusion criteria: Lack of patient consent Lack of communication skills Under 18 years old Comorbid psychological disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain and anxiety. Timepoint: Before and after the procedure. Method of measurement: Pain was assessed using the VAS questionnaire, and anxiety was assessed using the Beck questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications during the procedure. Timepoint: After procedure. Method of measurement: Pneumothorax was assessed using CXR (Chest X-ray), and hematoma was assessed through clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAida zeinali
Tehran University of Medical Sciences
Outcome results
None listed